I.B.I Investment House Ltd. (IBI.TA)
Tel Aviv, IL
I.B.I Investment House Ltd. operates as a publicly listed investment holding company, managing a significant portfolio of approximately NIS 11 billion (equivalent to $2.63 billion) in assets. Its financial solutions cater to a broad spectrum of clients, including both private individuals and large institutional entities. Through its network of subsidiary companies, IBI delivers a comprehensive suite of services, such as securities brokerage, financial advisory, and dedicated investment administration. This encompasses the diligent oversight of diverse investment portfolios, mutual funds, underwriting activities, and provident (pension) funds. The company, which maintains its headquarters in Tel Aviv, Israel, was established in 1971 and was formerly known as Gachelet Investment Co.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.57% | -6.73% | +15.34% | +27.60% | +85.63% | +75.67% | +126.37% | +453.34% | +581.49% | +1,894.70% | +1,974.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Financial - Conglomerates: +32.7%+41.3% ★ Q1'26: +5,831.0% (vs Q1'25)
-
EPS growth Financial - Conglomerates: +16.6%-4.3% Q1'26: +203.2% (vs Q1'25)
-
FCF margin FCF growth · Financial - Conglomerates: +2.3%+23.5% ★ Q1'26: +26.6% (vs Q1'25)
-
EBIT margin Financial - Conglomerates: +36.2%+28.9% Q1'26: +38.7% (vs Q1'25)
-
ROIC Financial - Conglomerates: +2.2%+30.2% ★ Q1'26: +70.3% (vs Q1'25)
-
Share dilution Financial - Conglomerates: +0.0%+7.8% Q1'26: +0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Financial - Conglomerates: 2.57×0.89× ★ Q1'26: 0.26× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-03 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-02 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-01 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-29 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Israel ETF EIS | 0.14% | 1.22M | 0.59% |
| 2 | Avantis International Small Cap Equity ETF AVDS | 0.02% | 54.5K | 0.30% |
| 3 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.02% | 35.1K | 0.83% |
| 4 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.02% | 2.11M | 0.40% |
| 5 | Vanguard MSCI International Small Cos Index ETF VISM.AX | 0.01% | 57.9K | 0.32% |
| 6 | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) WDSC.L | 0.00% | 64.4K | 0.45% |
| 7 | iShares Core MSCI EAFE ETF IEFA | 0.00% | 3.85M | 0.07% |
| 8 | iShares Core MSCI EAFE IMI Index ETF (CAD-Hedged) XFH.TO | 0.00% | 42.0K | 0.23% |
| 9 | iShares Core MSCI EAFE IMI Index ETF XEF.TO | 0.00% | 292.4K | 0.23% |
| 10 | iShares Core Equity ETF Portfolio XEQT.TO | 0.00% | 66.6K | 0.20% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Livnat Mizrahi Rinsky | Chief Executive Officer of IBI l Brokerage | 9M | female |
| Tal Dori | Chief Executive Officer of IBI Capital | 6M | male |
| Oren Cohen | Deputy Chief Executive Officer Marketing & Sales | 4M | male |
| David Lubetzky | Chief Executive Officer | 2M | male |
| Dror Tene | Chief Financial Officer | 2M | male |
| Ella Alkalay | Vice President of Business Development | 1M | female |
| Emanuel Kook | Founder & Partner | 160.0K | male |
| David Weisberg | Founder & Partner | 160.0K | male |
| Zvi Lubetzky | Founder & Partner | 160.0K | male |
| Ron Shuhatovich | Chief Legal Counsel | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IBI.TA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
